Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Sushree Mohanty

REVEALED: 2 growth stocks with 20 to 40 upside in 2024 - The Real Truth

A popular investment strategy among savvy investors is to diversify their portfolio by investing in growth stocks with strong fundamentals from various industries. Growth stocks in burgeoning industries are typically in their early stages, some possessing great long-term prospects. Here, we have two such growth stocks that have received a consensus "strong buy" rating from Wall Street analysts.

The first one is Skye Bioscience (SKYE), whose stock has soared 427.2% year-to-date, massively outperforming the S&P 500 Index’s ($SPX) gain of 10.6%. It is a biopharmaceutical company exploring the potential of cannabinoid-based therapeutics.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.